-->

Innovative therapeutics

Investors

NASDAQBMRN
FormDescriptionDateFormat
4Statement of changes in beneficial ownership of securitiesJun 10, 2019View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 7, 2019View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 7, 2019View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 7, 2019View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 7, 2019View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 7, 2019View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 6, 2019View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 6, 2019View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 6, 2019View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 6, 2019View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 6, 2019View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 6, 2019View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 6, 2019View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 6, 2019View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 6, 2019View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 6, 2019View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 6, 2019View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 14, 2019View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 13, 2019View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 9, 2019View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesApr 30, 2019View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesApr 18, 2019View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesApr 15, 2019View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesApr 9, 2019View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesApr 9, 2019View HTMLDownload DOCDownload PDF
1-25      26-50      51-75      76-100      101-103

BioMarin

Diseases

Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI, CLN2 disease) PKU, LEMS

Products

Palynziq™
Brineura™
Vimizim®
Kuvan®
Naglazyme®
Aldurazyme®
Firdapse®

Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: support@biomarin-rareconnections.com

Global Medical Information

Contact Global Medical Information